With regard to Bill C-26, An Act to amend the Controlled Drugs and Substances Act and to make consequential amendments to other Acts, and the government's anti-drug strategy: (a) what stakeholders were consulted in forming this strategy and what documents or studies relating to drug trends were analyzed; (b) what were the departmental recommendations regarding harm reduction; and (c) what documents were commissioned externally by government that contributed to the strategy?
In the House of Commons on March 7th, 2008. See this statement in context.